Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study

BACKGROUND: Bisphosphonates are common first line medications used for the management of benign bone disease. One of the most devastating complications associated with bisphosphonate use is osteonecrosis of the jaws which may be related to duration of exposure and hence cumulative dose, dental inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Borromeo, Gelsomina L, Brand, Caroline, Clement, John G, McCullough, Michael, Thomson, Wendy, Flitzanis, Elly, Wark, John D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080357/
https://www.ncbi.nlm.nih.gov/pubmed/21477374
http://dx.doi.org/10.1186/1471-2474-12-71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080357/
https://www.ncbi.nlm.nih.gov/pubmed/21477374
http://dx.doi.org/10.1186/1471-2474-12-71

Ejemplares similares